Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells

Cancer Letters

Volumn 299, Issue 2, 2010, Pages 119-129

  MacPherson, Laura ^a   Matthews, Jason ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aryl hydrocarbon receptor; Dioxin; Estrogen receptor; Kaempferol; Resveratrol

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DIOXIN; ESTROGEN RECEPTOR ALPHA; KAEMPFEROL; MESSENGER RNA; PICEATANNOL; RESVERATROL;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG STRUCTURE; GENE AMPLIFIED IN BREAST CANCER 1; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARYL HYDROCARBON HYDROXYLASES; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAEMPFEROLS; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; STILBENES; TERATOGENS; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION, GENETIC;

EID: 78049261850     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.08.010     Document Type: Article

References (44)

1. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 1995, 35:307-340.
2. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003, 43:309-334.
3. Ciolino H.P., Daschner P.J., Yeh G.C. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res. 1998, 58:5707-5712.
4. Casper R.F., Quesne M., Rogers I.M., Shirota T., Jolivet A., Milgrom E., Savouret J.F. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol. Pharmacol. 1999, 56:784-790.
5. Tian Y., Ke S., Denison M.S., Rabson A.B., Gallo M.A. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 1999, 274:510-515.
6. Puga A., Xia Y., Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem. Biol. Interact. 2002, 141:117-130.
7. Matthews J., Gustafsson J.A. Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl. Recept. Signal. 2006, 4:e016.
8. Nilsson S., Gustafsson J.A. Estrogen receptor transcription and transactivation: Basic aspects of estrogen action. Breast Cancer Res. 2000, 2:360-366.
9. Safe S., Wormke M. Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem. Res. Toxicol. 2003, 16:807-816.
10. Liu S., Abdelrahim M., Khan S., Ariazi E., Jordan V.C., Safe S. Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells. Biol. Chem. 2006, 387:1209-1213.
11. Athar M., Back J.H., Tang X., Kim K.H., Kopelovich L., Bickers D.R., Kim A.L. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 2007, 224:274-283.
12. Sampson L., Rimm E., Hollman P.C., de Vries J.H., Katan M.B. Flavonol and flavone intakes in US health professionals. J. Am. Diet Assoc. 2002, 102:1414-1420.
13. Kris-Etherton P.M., Keen C.L. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr. Opin. Lipidol. 2002, 13:41-49.
14. Mikstacka R., Baer-Dubowska W., Wieczorek M., Sobiak S. Thiomethylstilbenes as inhibitors of CYP1A1, CYP1A2 and CYP1B1 activities. Mol. Nutr. Food Res. 2008, 52(Suppl 1):S77-83.
15. Ung D., Nagar S. Trans-resveratrol-mediated inhibition of beta-oestradiol conjugation in MCF-7 cells stably expressing human sulfotransferases SULT1A1 or SULT1E1, and human liver microsomes. Xenobiotica 2009, 39:72-79.
16. Ciolino H.P., Daschner P.J., Yeh G.C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 1999, 340(Pt 3):715-722.
17. Beedanagari S.R., Bebenek I., Bui P., Hankinson O. Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes. Toxicol. Sci. 2009, 110:61-67.
18. Lancon A., Hanet N., Jannin B., Delmas D., Heydel J.M., Lizard G., Chagnon M.C., Artur Y., Latruffe N. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab. Dispos. 2007, 35:699-703.
19. Piver B., Fer M., Vitrac X., Merillon J.M., Dreano Y., Berthou F., Lucas D. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem. Pharmacol. 2004, 68:773-782.
20. Gehm B.D., McAndrews J.M., Chien P.Y., Jameson J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 1997, 94:14138-14143.
21. Harris D.M., Besselink E., Henning S.M., Go V.L., Heber D. Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells. Exp. Biol. Med. (Maywood) 2005, 230:558-568.
22. Matthews J., Wihlen B., Thomsen J., Gustafsson J.A. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol. Cell Biol. 2005, 25:5317-5328.
23. Tang Y.M., Wo Y.Y., Stewart J., Hawkins A.L., Griffin C.A., Sutter T.R., Greenlee W.F. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J. Biol. Chem. 1996, 271:28324-28330.
24. Ahmed S., Valen E., Sandelin A., Matthews J. Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor alpha at human promoters. Toxicol. Sci. 2009, 111:254-266.
25. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., Wang Q., Bekiranov S., Sementchenko V., Fox E.A., Silver P.A., Gingeras T.R., Liu X.S., Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 2006, 38:1289-1297.
26. Thomsen J.S., Wang X., Hines R.N., Safe S. Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis 1994, 15:933-937.
27. Puppala D., Gairola C.G., Swanson H.I. Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation. Carcinogenesis 2007, 28:639-647.
28. Taylor R.T., Wang F., Hsu E.L., Hankinson O. Roles of coactivator proteins in dioxin induction of CYP1A1 and CYP1B1 in human breast cancer cells. Toxicol. Sci. 2009, 107:1-8.
29. Signorelli P., Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 2005, 16:449-466.
30. DuPont M.S., Day A.J., Bennett R.N., Mellon F.A., Kroon P.A. Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. Eur. J. Clin. Nutr. 2004, 58:947-954.
31. Levenson A.S., Gehm B.D., Pearce S.T., Horiguchi J., Simons L.A., Ward J.E., Jameson J.L., Jordan V.C. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha. Int. J. Cancer 2003, 104:587-596.
32. Pike A.C., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A.G., Engstrom O., Ljunggren J., Gustafsson J.A., Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. Embo. J. 1999, 18:4608-4618.
33. Maggiolini M., Recchia A.G., Bonofiglio D., Catalano S., Vivacqua A., Carpino A., Rago V., Rossi R., Ando S. The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells. J. Mol. Endocrinol. 2005, 35:269-281.
34. Matsumura A., Ghosh A., Pope G.S., Darbre P.D. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 2005, 94:431-443.
35. Oh S.M., Kim Y.P., Chung K.H. Biphasic effects of kaempferol on the estrogenicity in human breast cancer cells. Arch. Pharm. Res. 2006, 29:354-362.
36. Bhat K.P., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Ann. N. Y. Acad. Sci. 2002, 957:210-229.
37. Gunther S., Ruhe C., Derikito M.G., Bose G., Sauer H., Wartenberg M. Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells. Cancer Lett. 2007, 250:25-35.
38. Sato M., Pei R.J., Yuri T., Danbara N., Nakane Y., Tsubura A. Prepubertal resveratrol exposure accelerates N-methyl-N-nitrosourea-induced mammary carcinoma in female Sprague-Dawley rats. Cancer Lett. 2003, 202:137-145.
39. Weitsman G.E., Skliris G., Ung K., Peng B., Younes M., Watson P.H., Murphy L.C. Assessment of multiple different estrogen receptor-beta antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions. Breast Cancer Res. Treat. 2006, 100:23-31.
40. Holownia A., Braszko J.J. Tamoxifen cytotoxicity in hepatoblastoma cells stably transfected with human CYP3A4. Biochem. Pharmacol. 2004, 67:1057-1064.
41. C.D. Dusell, E.R. Nelson, B.M. Wittmann, J.A. Fretz, D. Kazmin, R.S. Thomas, J.W. Pike, and D.P. McDonnell, Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators, Mol. Endocrinol. 24 33-46.
42. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
43. Vaziri H., Dessain S.K., Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001, 107:149-159.
44. Beher D., Wu J., Cumine S., Kim K.W., Lu S.C., Atangan L., Wang M. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem. Biol. Drug Des. 2009, 74:619-624.